XENE filings
Corporate insider profile
Gillian Cannon Filing Activity
Latest reported as Director of Xenon Pharmaceuticals Inc. (XENE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$63,236.60
- Latest transaction
- Jun 5, 2026
Affiliated corporations
Reported company relationships
Transaction history
